Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.45M Sell
36,960
-1,432
-4% -$165K 0.4% 60
2025
Q4
$4.04M Sell
38,392
-7,870
-17% -$739K 0.36% 61
2025
Q3
$3.88M Sell
46,262
-1,841
-4% -$152K 0.36% 65
2025
Q2
$3.81M Sell
48,103
-1,263
-3% -$100K 0.38% 66
2025
Q1
$4.43M Sell
49,366
-6,356
-11% -$593K 0.48% 51
2024
Q4
$5.54M Sell
55,722
-1,567
-3% -$162K 0.58% 42
2024
Q3
$6.51M Buy
57,289
+3,239
+6% +$385K 0.68% 38
2024
Q2
$6.69M Buy
54,050
+1,122
+2% +$145K 0.74% 35
2024
Q1
$6.98M Sell
52,928
-588
-1% -$72.5K 0.81% 32
2023
Q4
$5.83M Sell
53,516
-1,009
-2% -$105K 0.74% 37
2023
Q3
$5.61M Buy
54,525
+224
+0.4% +$24.1K 0.77% 37
2023
Q2
$6.27M Sell
54,301
-1,840
-3% -$209K 0.82% 35
2023
Q1
$5.97M Sell
56,141
-1,273
-2% -$137K 0.83% 34
2022
Q4
$6.37M Buy
57,414
+643
+1% +$65.7K 0.9% 32
2022
Q3
$4.89M Buy
56,771
+64
+0.1% +$5.71K 0.73% 39
2022
Q2
$5.17M Buy
56,707
+1,568
+3% +$139K 0.71% 40
2022
Q1
$4.52M Buy
55,139
+535
+1% +$42.2K 0.54% 47
2021
Q4
$4.18M Sell
54,604
-63
-0.1% -$5.02K 0.48% 48
2021
Q3
$4.11M Buy
54,667
+4,184
+8% +$318K 0.52% 47
2021
Q2
$3.93M Buy
50,483
+164
+0.3% +$12.2K 0.51% 47
2021
Q1
$3.7M Buy
50,319
+4,571
+10% +$337K 0.52% 46
2020
Q4
$3.57M Sell
45,748
-299
-0.6% -$22.9K 0.54% 47
2020
Q3
$3.64M Sell
46,047
-1,297
-3% -$102K 0.6% 47
2020
Q2
$3.49M Sell
47,344
-1,151
-2% -$86.6K 0.59% 49
2020
Q1
$3.56M Sell
48,495
-77
-0.2% -$6.05K 0.67% 46
2019
Q4
$4.22M Buy
+48,572
New +$3.99M 0.64% 51

Other funds holding MRK

Caldwell Trust's MRK Position: Q1 2026 in Review

Caldwell Trust reduced its Merck (MRK) stake by 3.7% in Q1 2026, selling an estimated $165K and leaving 36,960 shares worth $4.45M. The position accounts for 0.4% of the portfolio, ranked #60.

Caldwell Trust first reported a position in MRK in Q4 2019 and has held it in 26 quarters since. The position peaked at $6.98M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Caldwell Trust held 36,960 shares of Merck worth $4.45M as of Q1 2026.
  • Caldwell Trust sold 1,432 Merck shares in Q1 2026, an estimated $165K.
  • Merck made up 0.4% of Caldwell Trust's portfolio in Q1 2026, its #60 holding.
  • Caldwell Trust first reported a position in Merck in Q4 2019 and has held it in 26 quarters since.
  • Caldwell Trust's Merck position peaked at $6.98M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.